Standout Papers

Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxor... 2013 2026 2017 2021 357
  1. Randomized, Multicenter, Open-Label Study of Oxaliplatin Plus Fluorouracil/Leucovorin Versus Doxorubicin As Palliative Chemotherapy in Patients With Advanced Hepatocellular Carcinoma From Asia (2013)
    Shukui Qin, Yuxian Bai et al. Journal of Clinical Oncology

Immediate Impact

1 by Nobel laureates 3 from Science/Nature 66 standout
Sub-graph 1 of 21

Citing Papers

Ultrasound-Based Micro-/Nanosystems for Biomedical Applications
2024 Standout
Pathophysiology and Main Molecular Mechanisms of Urinary Stone Formation and Recurrence
2024 Standout
2 intermediate papers

Works of Yan Sun being referenced

Role of ROS-Induced NLRP3 Inflammasome Activation in the Formation of Calcium Oxalate Nephrolithiasis
2022
Atorvastatin inhibits renal inflammatory response induced by calcium oxalate crystals via inhibiting the activation of TLR4/NF‐κB and NLRP3 inflammasome
2020
and 1 more

Author Peers

Author Last Decade Papers Cites
Yan Sun 901 588 644 89 2.4k
Shingo Tsuji 1035 366 512 77 2.7k
Jian Dong 919 295 567 95 2.3k
Yang Wang 1288 231 598 100 2.7k
Luca Messerini 1006 705 1118 112 3.6k
Minoru Okuma 933 545 285 116 3.3k
David E. Dostal 2132 213 519 75 4.4k
Keiji Hirata 1140 398 1063 182 2.7k
Seong‐Hun Kim 1238 357 338 140 3.1k
Laura García‐Bermejo 1797 221 449 89 3.2k
Sandra Cerda 632 454 700 71 2.2k

All Works

Loading papers...

Rankless by CCL
2026